181 related articles for article (PubMed ID: 15454346)
1. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice.
Barna I; Zelena D; Arszovszki AC; Ledent C
Life Sci; 2004 Oct; 75(24):2959-70. PubMed ID: 15454346
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.
Muglia LJ; Jacobson L; Luedke C; Vogt SK; Schaefer ML; Dikkes P; Fukuda S; Sakai Y; Suda T; Majzoub JA
J Clin Invest; 2000 May; 105(9):1269-77. PubMed ID: 10792002
[TBL] [Abstract][Full Text] [Related]
3. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
4. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
[TBL] [Abstract][Full Text] [Related]
5. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
Wenger T; Ledent C; Tramu G
Neuroendocrinology; 2003 Dec; 78(6):294-300. PubMed ID: 14688442
[TBL] [Abstract][Full Text] [Related]
6. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.
Cota D; Steiner MA; Marsicano G; Cervino C; Herman JP; Grübler Y; Stalla J; Pasquali R; Lutz B; Stalla GK; Pagotto U
Endocrinology; 2007 Apr; 148(4):1574-81. PubMed ID: 17194743
[TBL] [Abstract][Full Text] [Related]
7. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
8. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.
Ginsberg AB; Pecoraro NC; Warne JP; Horneman HF; Dallman MF
Stress; 2010 May; 13(3):248-57. PubMed ID: 20392196
[TBL] [Abstract][Full Text] [Related]
9. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
[TBL] [Abstract][Full Text] [Related]
11. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
Ginsberg AB; Campeau S; Day HE; Spencer RL
J Neuroendocrinol; 2003 Nov; 15(11):1075-83. PubMed ID: 14622438
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.
Newsom RJ; Osterlund C; Masini CV; Day HE; Spencer RL; Campeau S
Neuroscience; 2012 Mar; 204():64-73. PubMed ID: 22138156
[TBL] [Abstract][Full Text] [Related]
14. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress.
Spencer SJ; Xu L; Clarke MA; Lemus M; Reichenbach A; Geenen B; Kozicz T; Andrews ZB
Biol Psychiatry; 2012 Sep; 72(6):457-65. PubMed ID: 22521145
[TBL] [Abstract][Full Text] [Related]
16. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
18. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
Thomas GB; Fairhall KM; Robinson IC
Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
[TBL] [Abstract][Full Text] [Related]
19. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
Huang TS
J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic.
Atkinson HC; Leggett JD; Wood SA; Castrique ES; Kershaw YM; Lightman SL
Endocrinology; 2010 Aug; 151(8):3720-7. PubMed ID: 20534730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
